Abstract
In the past, gastric resection was considered to be the first therapeutic step in primary gastric lymphoma (PGL). Since many of the advantages claimed in the past for the surgical approach have become less relevant, the stomach-conserving policy has become the standard. However, the advantages of non-surgical approach have not been confirmed by a prospective randomized trial of adequate size, and only a few prospective phase II studies have evaluated non-surgical treatment in histologically aggressive PGL. Literature data, concerned with the non-surgical treatment of PGL, is reviewed in this article. These data clearly indicate that surgery does not have any apparent diagnostic or therapeutic advantages and that aggressive PGL can be treated successfully with primary chemotherapy, with or without radiotherapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
